Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

High Court Gives Stryker Second Shot At Enhanced Damages

This article was originally published in Clinica

Executive Summary

A Supreme Court verdict handed down June 13 would give manufacturers a better chance at winning enhanced damages in patent suits.

You may also be interested in...



No Do-Over Needed In Supreme Court Patent Case, Stryker Says

The US Supreme Court doesn’t need to take a second look at a 2016 ruling on when parties found responsible for patent infringement must pay trebled damages, medical device giant Stryker told the court in a recent filing. Previously, federal courts had ordered fellow device-maker Zimmer to pay almost $250m to Stryker for violating patents on a wound-debridement device.

Judge Rules For Enhanced Damages In Zimmer-Stryker Patent Spat

The case had gone to the US Supreme Court due to a dispute over the standards for enhanced damages. Zimmer, which was ordered to pay almost $250m in costs and penalties, expects to appeal the verdict.

Appeals Court Upholds Willful Infringement Finding In Stryker-Zimmer Patent Spat

The Federal Circuit Court of Appeals sent the question of whether damages should be tripled back to the district court, but agreed Zimmer had willfully infringed the patents. The case was previously appealed to the Supreme Court, which said the previous appeals-court standard for enhanced damages was too strict.

Related Content

Topics

UsernamePublicRestriction

Register

MT103508

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel